Cholesterol Testing Brought Directly to Consumers

 

March 21, 2007

Cholestech Corp., provider of point-of-care health management solutions for chronic disease, and Life Line Screening, provider of mobile preventive health screenings, have teamed up to bring cholesterol, glucose and c-reactive protein testing directly to consumers across the country. With 85 vans across the U.S. and 1.4 million participants per year, Life Line Screening, the leader in the emerging trend of consumer-accessible screenings for stroke, vascular disease and osteoporosis has selected the Cholestech point-of-care testing system to screen Americans for risk factors‚ LDX associated with stroke, heart disease, diabetes and inflammatory disorders.

The LDX testing system will become part of Life Line Screening’s current preventive health services, which include non-invasive ultrasound screenings for stroke, abdominal aortic aneurysm, peripheral arterial disease and osteoporosis.

In collaboration with Cholestech, Life Line Screening can provide its participants laboratory-accurate results of their complete lipid panel, including total cholesterol, LDL, HDL and triglycerides; blood glucose; and high sensitivity C-reactive protein.